IL142876A0 - Nano-emulsion of 5-aminolevulinic acid - Google Patents

Nano-emulsion of 5-aminolevulinic acid

Info

Publication number
IL142876A0
IL142876A0 IL14287699A IL14287699A IL142876A0 IL 142876 A0 IL142876 A0 IL 142876A0 IL 14287699 A IL14287699 A IL 14287699A IL 14287699 A IL14287699 A IL 14287699A IL 142876 A0 IL142876 A0 IL 142876A0
Authority
IL
Israel
Prior art keywords
nano
emulsion
aminolevulinic acid
composition
well
Prior art date
Application number
IL14287699A
Other languages
English (en)
Original Assignee
Asat Ag Applied Science & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asat Ag Applied Science & Tech filed Critical Asat Ag Applied Science & Tech
Publication of IL142876A0 publication Critical patent/IL142876A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Radiation-Therapy Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14287699A 1998-11-12 1999-11-12 Nano-emulsion of 5-aminolevulinic acid IL142876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19852245A DE19852245A1 (de) 1998-11-12 1998-11-12 5-Aminolävulinsäure-Nanoemulsion
PCT/EP1999/008711 WO2000028971A1 (de) 1998-11-12 1999-11-12 5-aminolävulinsäure-nanoemulsion

Publications (1)

Publication Number Publication Date
IL142876A0 true IL142876A0 (en) 2002-03-10

Family

ID=7887602

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14287699A IL142876A0 (en) 1998-11-12 1999-11-12 Nano-emulsion of 5-aminolevulinic acid
IL142876A IL142876A (en) 1998-11-12 2001-04-30 Nano-emulsion of 5-aminolevulinic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142876A IL142876A (en) 1998-11-12 2001-04-30 Nano-emulsion of 5-aminolevulinic acid

Country Status (13)

Country Link
US (1) US6559183B1 (xx)
EP (1) EP1128812B1 (xx)
JP (1) JP2002529495A (xx)
AT (1) ATE260092T1 (xx)
AU (1) AU758098B2 (xx)
CA (1) CA2351620C (xx)
DE (2) DE19852245A1 (xx)
HK (1) HK1039893A1 (xx)
IL (2) IL142876A0 (xx)
NZ (1) NZ511351A (xx)
PT (1) PT1128812E (xx)
WO (1) WO2000028971A1 (xx)
ZA (1) ZA200104726B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE10063076A1 (de) * 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
DE10202487A1 (de) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
ATE493382T1 (de) * 2004-03-30 2011-01-15 Cosmo Oil Co Ltd 5-aminolevulinsäure-phosphatsalz, verfahren zu dessen herstellung und dessen verwendung
WO2006098966A2 (en) * 2005-03-09 2006-09-21 Combe Incorporated Stable mixed emulsions comprising semisolid dispersions of at least two discrete and distinctly different particle size ranges
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
CA2600288A1 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) * 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
CN103270168A (zh) 2010-12-24 2013-08-28 爱科来株式会社 癌细胞的检测方法
US9241921B2 (en) 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
EP3851161A1 (en) 2015-10-15 2021-07-21 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
CN105708788B (zh) * 2016-02-24 2018-12-21 济南梵康医疗科技有限公司 一种盐酸氨基酮戊酸纳米乳膏的制备方法
WO2018221291A1 (ja) * 2017-05-31 2018-12-06 Ｓｂｉファーマ株式会社 過活動膀胱の予防剤または治療剤
AU2018302103B2 (en) * 2017-07-17 2024-03-07 Sun Pharmaceutical Industries, Inc. Photodynamic therapy method for skin disorders
CN107233303A (zh) * 2017-08-07 2017-10-10 苏州纳美特生物科技有限公司 一种氨基酮戊酸冷霜及其制备方法和应用
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
CN1039283C (zh) * 1988-12-12 1998-07-29 Fmc公司 卟啉的应用
CH677886A5 (xx) 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5599831A (en) * 1994-05-27 1997-02-04 Poretz; Ronald D. Method of preparation of pharmaceutical compositions
EP0704209A1 (en) * 1994-09-20 1996-04-03 JOHNSON & JOHNSON MEDICAL, INC. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
FR2730932B1 (fr) * 1995-02-27 1997-04-04 Oreal Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
HU225148B1 (en) * 1995-03-10 2006-07-28 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy or diagnosis, products and kits comprising thereof and method of in vitro diagnosis by their using
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof

Also Published As

Publication number Publication date
CA2351620C (en) 2006-01-10
IL142876A (en) 2007-06-03
AU1271000A (en) 2000-06-05
DE59908665D1 (de) 2004-04-01
AU758098B2 (en) 2003-03-13
ATE260092T1 (de) 2004-03-15
WO2000028971A1 (de) 2000-05-25
CA2351620A1 (en) 2000-05-25
HK1039893A1 (zh) 2002-05-17
PT1128812E (pt) 2004-09-30
DE19852245A1 (de) 2000-05-18
NZ511351A (en) 2003-08-29
ZA200104726B (en) 2002-01-21
US6559183B1 (en) 2003-05-06
JP2002529495A (ja) 2002-09-10
EP1128812B1 (de) 2004-02-25
EP1128812A1 (de) 2001-09-05

Similar Documents

Publication Publication Date Title
ZA200104726B (en) Nano-emulsion of 5-aminolevulinic acid.
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
ZA9510277B (en) Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
CA2277877A1 (en) Nitric oxide synthase inhibitors
NO20014415D0 (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
CA2245066A1 (en) Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
ATE310493T1 (de) Methoden zur reduktion der adstringierenden wirkung von zinn enthaltenden zahnpastazusammensetzungen
GB9928822D0 (en) Stable high glycerol liquids comprising N-acyl amino acids and/or salts
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
MXPA04001231A (es) Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico.
EP1100522A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT
MY130441A (en) Solutions containing epinastin
HK1052137A1 (en) Stabilized ascorbic acid solutions.
WO2000015179A3 (en) Cosmetic composition
TR200003688T1 (tr) Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
WO1999050269A3 (de) Porphyrine und ihre verwendung als phptosensitizer
TR200102259T2 (tr) Yeni oral formülasyon
CA2376303A1 (en) Stabilized vitamin c formulations
IL128069A0 (en) Color comprising an agent containing pyrogallol entities a salt of iron (ii) and an organic acid
DK1091740T3 (da) Halvfaste vandige præparater til oral applikation af toltrazuril-sulfon
RS63804A (xx) Stabilne soli o-acetilsalicilne kiseline sa baznim amino kiselinama ii
CA2433343A1 (en) Cosmetic compositions containing rosemary extract and dha
TR200002293T2 (tr) Farmasötik bileşimler.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed